This inventor holds 1 USPTO granted patent. Top assignee: Biomerieux Sa. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Marc Regenmortel: Innovator in Retro Peptides and Vaccination
Introduction
Marc Regenmortel is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of retro peptides and their applications in vaccination and in vitro diagnosis.
Latest Patents
Marc Regenmortel holds a patent for "Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosis." This invention relates to retro peptides and antibodies, focusing on their use in preparing pharmaceutical compositions, especially vaccines, and for diagnosing various pathologies in vitro. He has 1 patent to his name.
Career Highlights
Marc is associated with bioMérieux SA, a company renowned for its expertise in in vitro diagnostics. His work has been pivotal in advancing the understanding and application of retro peptides in medical science.
Collaborations
Throughout his career, Marc has collaborated with esteemed colleagues such as Gilles Guichard and Sylviane Muller. These partnerships have contributed to the innovative research and development in his field.
Conclusion
Marc Regenmortel's contributions to the field of retro peptides and vaccination highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence advancements in medical diagnostics and vaccine development.